Life Technologies Corp  

(Public, NASDAQ:LIFE)   Watch this stock  
Find more results for NASDAQ:IVGN
- Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week     -
Open     -
Vol. 0.00
Mkt cap     -
P/E 0.00
Div/yield     -
EPS 2.71
Shares 172.83M
Beta     -
Inst. own 81%

Key stats and ratios

Q3 (Sep '13) 2012
Net profit margin 12.62% 11.33%
Operating margin 17.77% 17.51%
EBITD margin - 30.72%
Return on average assets 5.58% 4.83%
Return on average equity 9.68% 9.31%
Employees 10,000 -
CDP Score - -


5791 Van Allen Way
CARLSBAD, CA 92008-7321
United States - Map
+1-760-6037200 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Transcripts - SeekingAlpha


Life Technologies Corporation (Life Technologies) is a global life sciences company. The Company's systems, consumables and services enable scientific researchers and commercial markets to accelerate scientific exploration, to discoveries and developments that improve the quality of life. The Company's products are also used in forensics, food and water safety, animal health testing and other industrial applications. In July 2012, it acquired Pinpoint Genomics, Inc. In October 2012, the Company acquired Compendia Bioscience, a cancer bioinformatics company used by the pharmaceutical industry to identify gene targets for drug discovery and development. In November 2012, the Company acquired Advanced Microscopy Group (AMG). In April 2013, it announced the acquisition of KDR Biotech Co., Ltd. In June 2013, the Company announced the acquisition of Life Science Korea (LSK). In February 2014, Thermo Fisher Scientific Inc completed the acquisition of Life Technologies Corp.